Concepts (200)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Neuromyelitis Optica | 27 | 2024 | 266 | 4.360 |
Why?
|
| Aquaporin 4 | 25 | 2024 | 161 | 2.530 |
Why?
|
| Autoantibodies | 24 | 2024 | 2115 | 1.110 |
Why?
|
| Optic Neuritis | 6 | 2023 | 173 | 0.880 |
Why?
|
| Natural Killer T-Cells | 1 | 2022 | 319 | 0.650 |
Why?
|
| Multiple Sclerosis | 10 | 2024 | 3229 | 0.500 |
Why?
|
| Immunoglobulin G | 9 | 2024 | 4559 | 0.410 |
Why?
|
| Myelin P0 Protein | 1 | 2012 | 15 | 0.400 |
Why?
|
| Charcot-Marie-Tooth Disease | 1 | 2012 | 102 | 0.370 |
Why?
|
| Demyelinating Autoimmune Diseases, CNS | 2 | 2020 | 40 | 0.350 |
Why?
|
| Complement System Proteins | 2 | 2024 | 738 | 0.340 |
Why?
|
| Spinal Cord | 6 | 2023 | 1811 | 0.320 |
Why?
|
| Astrocytes | 6 | 2021 | 1351 | 0.300 |
Why?
|
| Encephalomyelitis, Autoimmune, Experimental | 2 | 2024 | 820 | 0.300 |
Why?
|
| Antibodies, Blocking | 2 | 2021 | 250 | 0.290 |
Why?
|
| Encephalitis | 2 | 2024 | 441 | 0.280 |
Why?
|
| Paraparesis | 2 | 2017 | 15 | 0.230 |
Why?
|
| Multiple Sclerosis, Relapsing-Remitting | 3 | 2020 | 551 | 0.220 |
Why?
|
| Hashimoto Disease | 1 | 2024 | 108 | 0.210 |
Why?
|
| Myelin Sheath | 2 | 2016 | 650 | 0.200 |
Why?
|
| Polyesters | 1 | 2024 | 373 | 0.200 |
Why?
|
| Receptors, Complement | 1 | 2022 | 254 | 0.200 |
Why?
|
| Antigen-Antibody Complex | 1 | 2024 | 512 | 0.200 |
Why?
|
| Immunosuppressive Agents | 3 | 2024 | 4215 | 0.190 |
Why?
|
| Pandemics | 1 | 2022 | 8734 | 0.190 |
Why?
|
| Churg-Strauss Syndrome | 1 | 2022 | 75 | 0.190 |
Why?
|
| Tremor | 2 | 2013 | 196 | 0.180 |
Why?
|
| Meningitis | 1 | 2022 | 219 | 0.170 |
Why?
|
| Prednisolone | 5 | 2024 | 326 | 0.170 |
Why?
|
| Methylprednisolone | 5 | 2017 | 387 | 0.170 |
Why?
|
| Japan | 5 | 2024 | 1418 | 0.170 |
Why?
|
| Aquaporins | 1 | 2021 | 176 | 0.170 |
Why?
|
| Complement Activation | 1 | 2021 | 447 | 0.160 |
Why?
|
| Receptors, IgG | 1 | 2022 | 562 | 0.160 |
Why?
|
| Antigen Presentation | 1 | 2024 | 1250 | 0.160 |
Why?
|
| Herpesvirus 4, Human | 1 | 2024 | 1080 | 0.160 |
Why?
|
| Neuroprotective Agents | 2 | 2023 | 956 | 0.160 |
Why?
|
| Sjogren's Syndrome | 1 | 2021 | 240 | 0.160 |
Why?
|
| Ophthalmoplegia, Chronic Progressive External | 1 | 2017 | 17 | 0.150 |
Why?
|
| Interleukin-17 | 1 | 2024 | 923 | 0.150 |
Why?
|
| Multiple Sclerosis, Chronic Progressive | 1 | 2020 | 253 | 0.140 |
Why?
|
| Cytokines | 3 | 2024 | 7438 | 0.140 |
Why?
|
| Diffuse Cerebral Sclerosis of Schilder | 1 | 2016 | 17 | 0.140 |
Why?
|
| Heavy Metal Poisoning, Nervous System | 1 | 2016 | 5 | 0.140 |
Why?
|
| Rodenticides | 1 | 2016 | 21 | 0.140 |
Why?
|
| Thallium | 1 | 2016 | 97 | 0.140 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2024 | 1852 | 0.140 |
Why?
|
| Biological Products | 1 | 2024 | 948 | 0.120 |
Why?
|
| Medulla Oblongata | 1 | 2016 | 247 | 0.120 |
Why?
|
| Seasons | 1 | 2020 | 1519 | 0.120 |
Why?
|
| Takotsubo Cardiomyopathy | 1 | 2016 | 125 | 0.120 |
Why?
|
| Retina | 2 | 2016 | 2660 | 0.120 |
Why?
|
| Glomerulosclerosis, Focal Segmental | 1 | 2017 | 336 | 0.110 |
Why?
|
| Humans | 50 | 2024 | 766812 | 0.110 |
Why?
|
| Bulbo-Spinal Atrophy, X-Linked | 1 | 2013 | 4 | 0.110 |
Why?
|
| Interleukin-6 | 1 | 2024 | 3226 | 0.110 |
Why?
|
| Propylene Glycols | 1 | 2014 | 91 | 0.110 |
Why?
|
| Earthquakes | 1 | 2016 | 192 | 0.110 |
Why?
|
| Killer Cells, Natural | 1 | 2022 | 2209 | 0.110 |
Why?
|
| Research | 1 | 2022 | 1977 | 0.110 |
Why?
|
| Recurrence | 6 | 2023 | 8507 | 0.110 |
Why?
|
| Optic Nerve Diseases | 1 | 2016 | 342 | 0.100 |
Why?
|
| Mutation | 3 | 2017 | 30214 | 0.100 |
Why?
|
| Ossification of Posterior Longitudinal Ligament | 1 | 2012 | 17 | 0.100 |
Why?
|
| Tacrolimus | 1 | 2016 | 753 | 0.100 |
Why?
|
| DNA, Mitochondrial | 1 | 2017 | 872 | 0.100 |
Why?
|
| Demyelinating Diseases | 1 | 2014 | 354 | 0.100 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2024 | 4410 | 0.100 |
Why?
|
| Encephalomyelitis | 1 | 2012 | 37 | 0.100 |
Why?
|
| Magnetic Resonance Imaging | 11 | 2022 | 36570 | 0.100 |
Why?
|
| Sphingosine | 1 | 2014 | 306 | 0.100 |
Why?
|
| Tomography, Emission-Computed, Single-Photon | 1 | 2016 | 1143 | 0.090 |
Why?
|
| Multienzyme Complexes | 1 | 2014 | 663 | 0.090 |
Why?
|
| Disease Progression | 3 | 2020 | 13642 | 0.090 |
Why?
|
| Neuroglia | 1 | 2016 | 960 | 0.090 |
Why?
|
| Peripheral Nervous System Diseases | 1 | 2016 | 713 | 0.090 |
Why?
|
| Frontal Lobe | 1 | 2017 | 1408 | 0.090 |
Why?
|
| Extracellular Space | 1 | 2012 | 563 | 0.090 |
Why?
|
| Disasters | 1 | 2016 | 521 | 0.090 |
Why?
|
| Disulfides | 1 | 2012 | 462 | 0.090 |
Why?
|
| Muscular Diseases | 1 | 2014 | 551 | 0.080 |
Why?
|
| Brain | 6 | 2021 | 27158 | 0.080 |
Why?
|
| Gait Disorders, Neurologic | 1 | 2012 | 244 | 0.080 |
Why?
|
| Parkinson Disease | 1 | 2023 | 2884 | 0.080 |
Why?
|
| Male | 30 | 2024 | 364154 | 0.080 |
Why?
|
| Blood-Brain Barrier | 2 | 2021 | 1028 | 0.080 |
Why?
|
| Postural Balance | 1 | 2013 | 637 | 0.080 |
Why?
|
| Plasmapheresis | 1 | 2009 | 205 | 0.080 |
Why?
|
| Glial Fibrillary Acidic Protein | 3 | 2016 | 564 | 0.080 |
Why?
|
| Leg | 1 | 2013 | 1087 | 0.080 |
Why?
|
| Adult | 23 | 2024 | 223305 | 0.080 |
Why?
|
| Leukocyte Count | 2 | 2023 | 1606 | 0.080 |
Why?
|
| Action Potentials | 2 | 2013 | 1835 | 0.070 |
Why?
|
| Sensory Receptor Cells | 1 | 2012 | 509 | 0.070 |
Why?
|
| Th17 Cells | 1 | 2014 | 790 | 0.070 |
Why?
|
| Eosinophilia | 1 | 2012 | 554 | 0.070 |
Why?
|
| Brain Diseases | 1 | 2016 | 1552 | 0.070 |
Why?
|
| Neurodegenerative Diseases | 1 | 2016 | 1089 | 0.070 |
Why?
|
| Middle Aged | 20 | 2024 | 223267 | 0.070 |
Why?
|
| Thrombocytopenia | 1 | 2014 | 1172 | 0.070 |
Why?
|
| Autoantigens | 2 | 2020 | 890 | 0.070 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2021 | 4050 | 0.060 |
Why?
|
| Amyotrophic Lateral Sclerosis | 1 | 2016 | 1481 | 0.060 |
Why?
|
| Head | 1 | 2011 | 926 | 0.060 |
Why?
|
| Young Adult | 10 | 2024 | 59939 | 0.060 |
Why?
|
| Antigens | 1 | 2010 | 1442 | 0.060 |
Why?
|
| Female | 23 | 2024 | 396532 | 0.060 |
Why?
|
| Glycols | 1 | 2024 | 54 | 0.060 |
Why?
|
| Receptor, Melanocortin, Type 1 | 1 | 2023 | 74 | 0.060 |
Why?
|
| Autoimmunity | 1 | 2010 | 1361 | 0.050 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2016 | 3230 | 0.050 |
Why?
|
| Age of Onset | 1 | 2009 | 3343 | 0.050 |
Why?
|
| Pulse Therapy, Drug | 2 | 2012 | 37 | 0.050 |
Why?
|
| Stress, Psychological | 1 | 2016 | 4526 | 0.040 |
Why?
|
| Epitopes, T-Lymphocyte | 1 | 2024 | 827 | 0.040 |
Why?
|
| Oligoclonal Bands | 1 | 2020 | 17 | 0.040 |
Why?
|
| Treatment Outcome | 6 | 2024 | 65286 | 0.040 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2014 | 3114 | 0.040 |
Why?
|
| Antibodies, Antineutrophil Cytoplasmic | 1 | 2022 | 297 | 0.040 |
Why?
|
| Antibodies, Anti-Idiotypic | 1 | 2021 | 347 | 0.040 |
Why?
|
| Optic Nerve | 1 | 2023 | 568 | 0.040 |
Why?
|
| Oligodendroglia | 1 | 2023 | 539 | 0.040 |
Why?
|
| Antibody Specificity | 1 | 2021 | 1062 | 0.040 |
Why?
|
| HEK293 Cells | 2 | 2022 | 4277 | 0.040 |
Why?
|
| Retrospective Studies | 6 | 2024 | 81657 | 0.040 |
Why?
|
| Endoplasmic Reticulum | 1 | 2024 | 1132 | 0.040 |
Why?
|
| Aged | 9 | 2021 | 171344 | 0.040 |
Why?
|
| Albumins | 1 | 2021 | 578 | 0.040 |
Why?
|
| Epstein-Barr Virus Infections | 1 | 2024 | 617 | 0.040 |
Why?
|
| Immunity | 1 | 2023 | 1002 | 0.040 |
Why?
|
| Glycoproteins | 1 | 2024 | 2201 | 0.030 |
Why?
|
| Atrophy | 1 | 2022 | 1631 | 0.030 |
Why?
|
| Sirolimus | 1 | 2024 | 1540 | 0.030 |
Why?
|
| Dopamine | 1 | 2023 | 1581 | 0.030 |
Why?
|
| Antibodies, Monoclonal | 1 | 2013 | 9244 | 0.030 |
Why?
|
| Lipopolysaccharides | 1 | 2023 | 2215 | 0.030 |
Why?
|
| Biopsy | 2 | 2017 | 6779 | 0.030 |
Why?
|
| Adolescent | 6 | 2021 | 88902 | 0.030 |
Why?
|
| Mice, Inbred C57BL | 2 | 2024 | 22351 | 0.030 |
Why?
|
| Myelitis, Transverse | 1 | 2014 | 40 | 0.030 |
Why?
|
| Phenotype | 1 | 2012 | 16722 | 0.030 |
Why?
|
| Lymphocyte Activation | 1 | 2024 | 5502 | 0.030 |
Why?
|
| Aquaporin 1 | 1 | 2013 | 59 | 0.030 |
Why?
|
| Disability Evaluation | 1 | 2020 | 1828 | 0.030 |
Why?
|
| Podocytes | 1 | 2017 | 404 | 0.030 |
Why?
|
| Flow Cytometry | 2 | 2014 | 5890 | 0.030 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2016 | 627 | 0.030 |
Why?
|
| Animals | 6 | 2024 | 168939 | 0.030 |
Why?
|
| Neural Conduction | 1 | 2013 | 442 | 0.020 |
Why?
|
| Alopecia | 1 | 2016 | 416 | 0.020 |
Why?
|
| Rats | 2 | 2023 | 23717 | 0.020 |
Why?
|
| Follow-Up Studies | 3 | 2022 | 39312 | 0.020 |
Why?
|
| Orbit | 1 | 2015 | 459 | 0.020 |
Why?
|
| Visual Pathways | 1 | 2016 | 554 | 0.020 |
Why?
|
| Housing | 1 | 2016 | 683 | 0.020 |
Why?
|
| Xenopus | 1 | 2013 | 710 | 0.020 |
Why?
|
| B-Lymphocytes | 1 | 2024 | 4787 | 0.020 |
Why?
|
| Clonazepam | 1 | 2011 | 135 | 0.020 |
Why?
|
| Muscle, Skeletal | 2 | 2017 | 4968 | 0.020 |
Why?
|
| Eye | 1 | 2015 | 711 | 0.020 |
Why?
|
| CHO Cells | 1 | 2013 | 1376 | 0.020 |
Why?
|
| Child | 4 | 2021 | 80670 | 0.020 |
Why?
|
| Siblings | 1 | 2014 | 828 | 0.020 |
Why?
|
| Cricetinae | 1 | 2013 | 2416 | 0.020 |
Why?
|
| Pedigree | 1 | 2016 | 4539 | 0.020 |
Why?
|
| Oocytes | 1 | 2013 | 1168 | 0.020 |
Why?
|
| Cell Separation | 1 | 2014 | 1718 | 0.020 |
Why?
|
| Time Factors | 1 | 2009 | 40149 | 0.020 |
Why?
|
| Glucocorticoids | 1 | 2017 | 2158 | 0.020 |
Why?
|
| Mice | 2 | 2024 | 81898 | 0.020 |
Why?
|
| Chronic Disease | 1 | 2021 | 9358 | 0.020 |
Why?
|
| Protein Structure, Tertiary | 1 | 2013 | 3759 | 0.020 |
Why?
|
| Cerebrovascular Circulation | 1 | 2016 | 2671 | 0.020 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2013 | 3803 | 0.020 |
Why?
|
| Visual Acuity | 1 | 2016 | 2714 | 0.020 |
Why?
|
| Cohort Studies | 2 | 2021 | 41706 | 0.020 |
Why?
|
| Cervical Vertebrae | 1 | 2011 | 978 | 0.010 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 1 | 2016 | 2809 | 0.010 |
Why?
|
| Cross-Sectional Studies | 2 | 2018 | 26309 | 0.010 |
Why?
|
| Recovery of Function | 1 | 2015 | 2978 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2023 | 18329 | 0.010 |
Why?
|
| Blood Platelets | 1 | 2014 | 2465 | 0.010 |
Why?
|
| Kidney Failure, Chronic | 1 | 2016 | 2505 | 0.010 |
Why?
|
| Acute Disease | 1 | 2014 | 7240 | 0.010 |
Why?
|
| Recombinant Proteins | 1 | 2013 | 6507 | 0.010 |
Why?
|
| Inflammation | 1 | 2023 | 10863 | 0.010 |
Why?
|
| Electrocardiography | 1 | 2016 | 6408 | 0.010 |
Why?
|
| Lung | 1 | 2021 | 10068 | 0.010 |
Why?
|
| Kidney | 1 | 2017 | 7073 | 0.010 |
Why?
|
| Blindness | 1 | 2006 | 585 | 0.010 |
Why?
|
| Amino Acid Sequence | 1 | 2013 | 13411 | 0.010 |
Why?
|
| Anticonvulsants | 1 | 2011 | 1921 | 0.010 |
Why?
|
| Protein Binding | 1 | 2013 | 9326 | 0.010 |
Why?
|
| Kidney Transplantation | 1 | 2016 | 4278 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2013 | 17609 | 0.010 |
Why?
|
| Algorithms | 1 | 2021 | 14073 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2018 | 22248 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2018 | 42577 | 0.010 |
Why?
|
| Prognosis | 1 | 2016 | 29959 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2013 | 59548 | 0.000 |
Why?
|
Concepts
(200)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(12)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_